Opinion: Inconsistent clinical practices thwart wider use of personalized medicine
The promise of personalized medicine — safer and more effective treatments tailored to each individual’s body and needs — isn’t being fully met because of challenges associated with its implementation in clinical practice.
In a special report published today in JCO Precision Oncology, we and our colleagues from Diaceutics, the Personalized Medicine Coalition, and Reservoir Communications provide the first in-depth look at the efforts of United States health systems to deploy potentially paradigm-shifting drugs that can be used to target specific genetic vulnerabilities in cancer cells.
